Korro Bio, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Korro Bio, Inc. (KRRO) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$117.82 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-12
- Korro Bio, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$117.82M.
- Korro Bio, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$83.50M.
- Korro Bio, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$81.14M.
- Korro Bio, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$81.59M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$117.82M 10-K · filed 2026-03-12 |
| 2024-12-31 | -$83.50M 10-K · filed 2026-03-12 |
| 2023-12-31 | -$81.14M 10-K · filed 2025-03-18 |
| 2022-12-31 | -$81.59M 10-K · filed 2023-03-10 |
| 2021-12-31 | -$84.62M 10-K · filed 2023-03-10 |
| 2020-12-31 | -$25.74M 10-K · filed 2022-03-15 |
| 2019-12-31 | -$19.09M 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |